{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:11:31Z","timestamp":1792642291825,"version":"4.5.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pulse field ablation (PFA) is a novel catheter ablation technology with potential safety benefits due to its tissue selectivity. It has the potential to directly damage or interact with the functionality of cardiac implantable electronic devices (CIEDs) in the form of electromagnetic interference (EMI). The aim of our study was to assess the impact of PFA on CIEDs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PFA lesions (45 per CIED) were applied from the Farapulse system to CIEDs (&lt; 5 cm from the lead tip and &lt; 15 cm from the generator). All devices were checked before and after PFA application for proper sensing and pacing functionality as well as for integrity of shock circuits in ICDs using a heart simulator. Moreover, devices were then interrogated for any spontaneous reprogramming, mode switching or other EMI effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In total, 44 CIEDs were tested (16 pacemaker, 21 ICDs, 7 CRT-P\/D) with 1980 PFA applications. There was no change in device settings, functionality and electrical parameters, and there was no macroscopic damage to the devices. The risk of damage to the electric components or leads on a patient-based analysis is 0\/44 (95% CI 0\u20138%) and on a PFA pulse-based analysis is 0\/1980 (95% CI 0\u20130.2%). Clinically relevant EMI appeared with oversensing and pacing inhibition but not tachycardia detection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Bipolar PFA appears safe and does not result in damage to CIEDs or leads. Clinically relevant EMI does occur, but appropriate peri-procedural programming may mitigate this.\n                      <jats:italic>In vivo<\/jats:italic>\n                      studies are needed to confirm our findings.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10840-024-01758-2","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T03:01:46Z","timestamp":1716346906000},"page":"1635-1641","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Pulsed field ablation in patients with cardiac implantable electronic devices: an ex vivo assessment of safety"],"prefix":"10.1007","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1693-6474","authenticated-orcid":false,"given":"Carsten","family":"Lennerz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Schaarschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilko","family":"Reents","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Bourier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Telishevska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Lengauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miruna","family":"Popa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Wimbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Holmgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Thoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lovis","family":"Spitzauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Bahlke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Krafft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Englert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Knoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Blazek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Hessling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Kolb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Deisenhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Kottmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,22]]},"reference":[{"key":"1758_CR1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021;42:373\u2013498. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612.","journal-title":"Eur Heart J"},{"key":"1758_CR2","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1111\/jce.14567","volume":"31","author":"S Tohoku","year":"2020","unstructured":"Tohoku S, Chen S, Last J, Bordignon S, Bologna F, Trolese L, et al. Phrenic nerve injury in atrial fibrillation ablation using balloon catheters: incidence, characteristics, and clinical recovery course. J Cardiovasc Electrophysiol. 2020;31:1932\u201341. https:\/\/doi.org\/10.1111\/jce.14567.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"1758_CR3","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/jama.2019.0693","volume":"321","author":"DL Packer","year":"2019","unstructured":"Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Poole JE, et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation. JAMA. 2019;321:1261. https:\/\/doi.org\/10.1001\/jama.2019.0693.","journal-title":"JAMA"},{"key":"1758_CR4","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1093\/europace\/euac033","volume":"24","author":"A Sugrue","year":"2022","unstructured":"Sugrue A, Maor E, Del-Carpio Munoz F, Killu AM, Asirvatham SJ. Cardiac ablation with pulsed electric fields: principles and biophysics. Europace. 2022;24:1213\u201322. https:\/\/doi.org\/10.1093\/europace\/euac033.","journal-title":"Europace"},{"key":"1758_CR5","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.jacep.2018.04.005","volume":"4","author":"VY Reddy","year":"2018","unstructured":"Reddy VY, Koruth J, Jais P, Petru J, Timko F, Skalsky I, et al. Ablation of atrial fibrillation with pulsed electric fields. JACC Clin Electrophysiol. 2018;4:987\u201395. https:\/\/doi.org\/10.1016\/j.jacep.2018.04.005.","journal-title":"JACC Clin Electrophysiol"},{"key":"1758_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jacc.2019.04.021","volume":"74","author":"VY Reddy","year":"2019","unstructured":"Reddy VY, Neuzil P, Koruth JS, Petru J, Funosako M, Cochet H, et al. Pulsed field ablation for pulmonary vein isolation in atrial fibrillation. J Am Coll Cardiol. 2019;74:315\u201326. https:\/\/doi.org\/10.1016\/j.jacc.2019.04.021.","journal-title":"J Am Coll Cardiol"},{"key":"1758_CR7","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1093\/europace\/euac050","volume":"24","author":"E Ekanem","year":"2022","unstructured":"Ekanem E, Reddy VY, Schmidt B, Reichlin T, Neven K, Metzner A, et al. Multi-national survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF). EP Eur. 2022;24:1256\u201366. https:\/\/doi.org\/10.1093\/europace\/euac050.","journal-title":"EP Eur"},{"key":"1758_CR8","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1093\/europace\/euab090","volume":"23","author":"H Cochet","year":"2021","unstructured":"Cochet H, Nakatani Y, Sridi-Cheniti S, Cheniti G, Ramirez FD, Nakashima T, et al. Pulsed field ablation selectively spares the oesophagus during pulmonary vein isolation for atrial fibrillation. EP Eur. 2021;23:1391\u20139. https:\/\/doi.org\/10.1093\/europace\/euab090.","journal-title":"EP Eur"},{"key":"1758_CR9","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1016\/j.hrthm.2015.05.012","volume":"12","author":"VJHM van Driel","year":"2015","unstructured":"van Driel VJHM, Neven K, van Wessel H, Vink A, Doevendans PAFM, Wittkampf FHM. Low vulnerability of the right phrenic nerve to electroporation ablation. Hear Rhythm. 2015;12:1838\u201344. https:\/\/doi.org\/10.1016\/j.hrthm.2015.05.012.","journal-title":"Hear Rhythm"},{"key":"1758_CR10","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.jacep.2021.02.014","volume":"7","author":"VY Reddy","year":"2021","unstructured":"Reddy VY, Dukkipati SR, Neuzil P, Anic A, Petru J, Funasako M, et al. Pulsed field ablation of paroxysmal atrial fibrillation: 1-year outcomes of IMPULSE, PEFCAT, and PEFCAT II. JACC Clin Electrophysiol. 2021;7:614\u201327. https:\/\/doi.org\/10.1016\/j.jacep.2021.02.014.","journal-title":"JACC Clin Electrophysiol"},{"key":"1758_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12938-020-00827-7","volume":"19","author":"T Jarm","year":"2020","unstructured":"Jarm T, Krmac T, Magjarevic R, Kos B, Cindric H, Miklavcic D. Investigation of safety for electrochemotherapy and irreversible electroporation ablation therapies in patients with cardiac pacemakers. Biomed Eng Online. 2020;19:85. https:\/\/doi.org\/10.1186\/s12938-020-00827-7.","journal-title":"Biomed Eng Online"},{"key":"1758_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-022-01445-0","author":"S Chen","year":"2022","unstructured":"Chen S, Chun JKR, Bordignon S, Tohoku S, Urbanek L, Schaack D, et al. Pulsed field ablation-based pulmonary vein isolation in atrial fibrillation patients with cardiac implantable electronic devices: practical approach and device interrogation (PFA in CIEDs). J Interv Card Electrophysiol. 2022. https:\/\/doi.org\/10.1007\/s10840-022-01445-0.","journal-title":"J Interv Card Electrophysiol"},{"key":"1758_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/pace.14629","author":"S Chen","year":"2022","unstructured":"Chen S, Schmidt B, Bordignon S, Tohoku S, Urbanek L, Chun JKR. Pulsed field ablation as first-line treatment to reduce atrial fibrillation burden documented by pacemaker. Pacing Clin Electrophysiol. 2022. https:\/\/doi.org\/10.1111\/pace.14629.","journal-title":"Pacing Clin Electrophysiol"},{"key":"1758_CR14","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1093\/europace\/euac040","volume":"24","author":"M St\u00fchlinger","year":"2022","unstructured":"St\u00fchlinger M, Burri H, Vernooy K, Garcia R, Lenarczyk R, Sultan A, et al. EHRA consensus on prevention and management of interference due to medical procedures in patients with cardiac implantable electronic devices. EP Eur. 2022;24:1512\u201337. https:\/\/doi.org\/10.1093\/europace\/euac040.","journal-title":"EP Eur"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-024-01758-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-024-01758-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-024-01758-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:54:49Z","timestamp":1792572889000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-024-01758-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,22]]},"references-count":14,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["1758"],"URL":"https:\/\/doi.org\/10.1007\/s10840-024-01758-2","relation":{},"ISSN":["1572-8595"],"issn-type":[{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,22]]},"assertion":[{"value":"4 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}